Drug Shortage Report for CLINDAMYCIN INJECTION USP

Last updated on 2023-02-01 History
Report ID 131817
Drug Identification Number 02230535
Brand name CLINDAMYCIN INJECTION USP
Common or Proper name CLINDAMYCIN INJECTION USP
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) CLINDAMYCIN
Strength(s) 150MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 60 ML 1LIVI CA
ATC code J01FF
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2021-01-15
Estimated end date 2023-02-03
Actual end date 2023-01-31
Shortage status Resolved
Updated date 2023-02-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2023-02-01 English Compare
v14 2023-01-31 French Compare
v13 2023-01-31 English Compare
v12 2023-01-19 French Compare
v11 2023-01-19 English Compare
v10 2022-04-05 French Compare
v9 2022-04-05 English Compare
v8 2022-01-26 French Compare
v7 2022-01-26 English Compare
v6 2021-06-28 French Compare
v5 2021-06-28 English Compare
v4 2021-03-15 French Compare
v3 2021-03-15 English Compare
v2 2021-01-18 French Compare
v1 2021-01-18 English Compare

Showing 1 to 15 of 15